Back
ESC Premium Access

Primary hemostatic disorders drive early and late major bleedings of patients with atrial fibrillation after transcatheter aortic valve replacement

Session: Valvular heart disease and infective endocarditis e-posters
Topic: Intervention
Speaker: Doctor K. Matsushita (Yokohama, JP)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Doctor Kensuke Matsushita

Yokochama City Uniersity Medical Center, Yokohama (Japan)
0 follower

130 more presentations in this session

Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis

Speaker: Doctor N. Ngiam (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.

Speaker: Doctor Z. Cheng (Chengdu, CN)

Access
Abstract
Slides
Like
Thumbnail

Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience

Speaker: Doctor S. Mahmood (Detroit, US)

Access
Abstract
Slides
Like
Thumbnail

Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis

Speaker: Doctor T. Sugimoto (Nagoya, JP)

Access
Abstract
Slides
Like
Thumbnail

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

Speaker: Doctor V. Jimenez Franco (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Valvular heart disease and infective endocarditis e-posters

Speakers: Doctor K. Matsushita, Doctor N. Ngiam, Doctor Z. Cheng, Doctor S. Mahmood, Doctor T. Sugimoto...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources